U.S. Markets open in 1 hr 15 mins

Merck’s Inorganic Growth Strategy in 2019

Margaret Patrick
Merck’s Inorganic Growth Strategy in 2019

On April 2, Merck & Co. issued a press release announcing the successful completion of its cash tender offer for Immune Design, with 86.75% of the target’s total outstanding common stock tendered on a fully diluted basis.